Diabetes and Healthy Aging

Why Diabetes Management Changes With Age

The relationship between diabetes and healthy aging is more complex — and more nuanced — than diabetes management at younger ages. Older adults with diabetes face a unique combination of challenges: the same long-term microvascular and macrovascular complications that affect all people with diabetes, compounded by the physiological changes of aging that alter medication metabolism, increase fall and fracture risk, reduce hypoglycemia awareness, and introduce competing priorities among multiple chronic conditions managed simultaneously. Yet aging with diabetes does not have to mean declining health and lost independence. With individualized, age-appropriate management that prioritizes functional preservation, safety from hypoglycemia, and quality of life alongside glucose control, the majority of older adults with diabetes can maintain good health and meaningful independence well into their later years. Our guide on what is diabetes provides foundational context; this article focuses on the specific considerations that make diabetes care different — and in many ways more nuanced — in older adults.

The prevalence of diabetes in older adults is striking: approximately 25–30% of adults over age 65 in the United States have diabetes, making it one of the most common chronic conditions in this age group. The majority have Type 2 diabetes, many of whom were diagnosed in middle age and have lived with the condition for decades. A smaller but significant proportion have Type 1 diabetes who are living longer than previous generations — the “graying” of Type 1 diabetes presenting unique management challenges as insulin-dependent individuals encounter the comorbidities and physiological changes of aging. Our guide on diabetes in older adults covers the epidemiology and general approach; this article focuses on specific domains of healthy aging management.

Diabetes in Older Adults: Why Goals Must Be Individualized The ADA explicitly recommends that blood glucose targets for older adults be individualized based on health status, functional status, life expectancy, and patient preferences — rather than applied uniformly. An otherwise healthy 70-year-old with few comorbidities may appropriately target HbA1c below 7.5%, while a frail 85-year-old with multiple comorbidities, cognitive impairment, and limited life expectancy may have an appropriate HbA1c target of below 8.5% — primarily to avoid symptomatic hyperglycemia and hypoglycemia while minimizing treatment burden. This individualization is not lowering standards — it is recognizing that the risks of aggressive glucose lowering (hypoglycemia, falls, medication burden) may outweigh the benefits of tight control in older, frailer patients where long-term complication prevention is less relevant than near-term safety and quality of life.

Hypoglycemia Risk in Older Adults With Diabetes

Hypoglycemia is the most dangerous acute complication of diabetes treatment in older adults, and its consequences are more severe in this population than at younger ages. The reasons are multiple:

Impaired hypoglycemia awareness: Older adults with diabetes — particularly those with long-standing diabetes and autonomic neuropathy — may lose the early warning symptoms (sweating, trembling, heart pounding) that normally alert a person to falling blood glucose. This hypoglycemia unawareness means that blood glucose can fall to dangerous levels without conscious recognition, leading directly to severe hypoglycemia without an opportunity to intervene. Our guide on diabetes and nerve damage covers the autonomic neuropathy that impairs the adrenergic warning system.
Fall and fracture risk: Hypoglycemia causes dizziness, impaired coordination, and confusion — each of which dramatically increases fall risk in older adults already vulnerable to falls from neuropathy, orthostatic hypotension, and balance impairment. Hip fractures from falls during hypoglycemia are associated with devastating outcomes in older adults, including prolonged hospitalization, permanent loss of mobility, and significantly increased mortality.
Cognitive effects: The brain in older adults is more vulnerable to the effects of hypoglycemia. Repeated or severe hypoglycemia is associated with accelerated cognitive decline and increased dementia risk — an association of particular concern given that dementia and diabetes both increase in prevalence with advancing age. Protecting cognitive function in older adults with diabetes requires prioritizing hypoglycemia avoidance alongside conventional diabetes management goals.
Cardiac arrhythmia risk: Hypoglycemia triggers adrenergic activation that can cause cardiac arrhythmias (QT interval prolongation, ventricular arrhythmias) — a risk that is particularly significant in older adults with pre-existing cardiovascular disease and conduction abnormalities. Nocturnal hypoglycemia carries cardiac risk that may contribute to the increased mortality seen in some intensive glycemic control trials in older adults with established cardiovascular disease.

The practical implication is that glucose-lowering medications with high hypoglycemia risk — particularly insulin and sulfonylureas — should be used with particular caution in older adults, with doses titrated conservatively, glucose targets relaxed compared to younger patients, and close monitoring maintained when any medication, diet, or activity change is made.

elderly person with diabetes reviewing medications with a pharmacist highlighting polypharmacy risks in older adults — Polypharmacy — the use of multiple medications simultaneously — is nearly universal in older adults with diabetes, who typically manage diabetes alongside hypertension, heart disease, arthritis, and other conditions, creating risks of dangerous drug interactions and hypoglycemia.

Medication Management in Older Adults With Diabetes

Polypharmacy — the use of five or more medications simultaneously — is almost universal in older adults with diabetes, who typically manage hypertension, dyslipidemia, cardiovascular disease, arthritis, osteoporosis, and other conditions alongside diabetes. The Beers Criteria (published by the American Geriatrics Society) identifies medications that are potentially inappropriate in older adults based on their side effect profiles and risk-benefit ratios in this population — several diabetes medications are specifically highlighted:

Glyburide (a long-acting sulfonylurea) is explicitly listed on the Beers Criteria as inappropriate for older adults due to its prolonged duration of action and high risk of severe, prolonged hypoglycemia. Shorter-acting sulfonylureas (glipizide) or non-sulfonylurea alternatives should be preferred when a secretagogue is needed.
Sliding scale insulin without scheduled basal insulin — a common approach in hospital settings — causes glucose instability and is associated with worse outcomes than more consistent insulin regimens in older hospitalized adults with diabetes.
Metformin requires dose adjustment and monitoring as kidney function declines with age, but is otherwise well-tolerated and beneficial in older adults. It should be held around iodinated contrast procedures and major surgeries due to lactic acidosis risk.
SGLT-2 inhibitors carry risks of volume depletion and urinary tract infections that may be more pronounced in older adults — particularly those on diuretics or with pre-existing kidney disease — requiring careful monitoring. However, their cardiovascular and kidney-protective benefits persist in older adults and often make them appropriate choices despite these cautions.
DPP-4 inhibitors (sitagliptin, linagliptin, alogliptin) are generally well-tolerated in older adults with low hypoglycemia risk, mild glucose lowering, and no weight gain — making them frequently preferred agents for older adults who need glucose lowering beyond metformin without hypoglycemia risk.

A periodic comprehensive medication review — ideally by a clinical pharmacist or geriatrician alongside the diabetes care team — to identify potentially inappropriate medications, eliminate redundant therapies, reduce polypharmacy burden, and simplify regimens to the minimum necessary to achieve individualized goals is strongly recommended for all older adults with diabetes. Our guide on diabetes and high blood pressure covers the blood pressure medications that must be carefully managed in the context of fall risk and kidney function in older adults.

Geriatric Syndromes and Diabetes

Several “geriatric syndromes” — conditions that are not diseases per se but rather common presentations of aging vulnerability — intersect with and are worsened by diabetes:

Cognitive impairment and dementia: Diabetes increases the risk of Alzheimer’s disease and vascular dementia by 50–100%. The mechanisms include cerebrovascular disease (diabetes accelerates atherosclerosis of cerebral blood vessels), AGE accumulation in brain tissue, insulin signaling dysregulation in the brain, and the inflammatory environment of chronic hyperglycemia. Cognitive impairment impairs the capacity for complex diabetes self-management — glucose monitoring, carbohydrate counting, injection technique — requiring simplification of treatment regimens and increasing involvement of caregivers. Our guide on diabetes and mental health covers cognitive effects of blood glucose fluctuations that compound the dementia risk.
Falls and fractures: Diabetes increases fall risk through peripheral neuropathy (impaired proprioception and balance), orthostatic hypotension (from autonomic neuropathy and antihypertensive medications), hypoglycemia, visual impairment from retinopathy, and lower extremity weakness. Diabetes also increases fracture risk despite normal or high bone mineral density — an effect attributed to AGE-induced collagen cross-linking that impairs bone toughness. Fall prevention strategies (balance training, home safety assessment, medication review, vitamin D and calcium supplementation, appropriate footwear) are essential components of comprehensive diabetes care in older adults. Our guide on diabetes and nerve damage covers the neuropathic contributions to fall risk.
Sarcopenia and frailty: Loss of muscle mass (sarcopenia) accelerates with age and is worsened by diabetes — insulin resistance impairs anabolic signaling in muscle, chronic hyperglycemia promotes muscle protein breakdown, and physical inactivity from neuropathic pain and fatigue further accelerates muscle loss. Sarcopenia worsens insulin resistance (muscle is the primary site of glucose disposal), creates a metabolic cycle in which worse sarcopenia drives worse diabetes drives worse sarcopenia. Resistance exercise — even gentle resistance exercise in chair-based formats for frail older adults — is the most effective intervention to preserve muscle mass and is strongly recommended for older adults with diabetes alongside aerobic activity.
Depression and social isolation: As covered in our guide on diabetes and mental health, depression is two to three times more common in people with diabetes. In older adults, depression is amplified by social isolation, bereavement, functional decline, and the burden of managing multiple chronic conditions simultaneously — and remains undertreated despite its profound impact on self-care capacity and quality of life.

Nutrition and Physical Activity for Diabetes and Healthy Aging

Nutrition and physical activity recommendations for older adults with diabetes build on the general diabetes guidelines while incorporating age-specific considerations:

Protein adequacy: Older adults with diabetes need higher protein intake than the standard recommendation (0.8 g/kg/day) to preserve muscle mass in the setting of anabolic resistance — approximately 1.0–1.2 g/kg/day for healthy older adults, higher for those who are frail or recovering from illness. Plant-based protein sources (legumes, soy, nuts) provide protein alongside fiber that benefits gut and cardiovascular health; lean animal proteins (fish, poultry, low-fat dairy) are also appropriate. Protein-rich meals slow gastric emptying and reduce postprandial glucose spikes, providing dual benefit for muscle preservation and glycemic control.
Micronutrient attention: Older adults with diabetes are at particular risk for vitamin D deficiency (impaired synthesis from reduced sun exposure and renal hydroxylation), vitamin B12 deficiency (from long-term metformin use and reduced gastric acid production that impairs B12 absorption), and magnesium deficiency (from urinary losses associated with glycosuria). Routine assessment and supplementation where deficient is appropriate.
Exercise adaptations: The general recommendation of 150 minutes per week of moderate aerobic activity remains appropriate for healthy older adults with diabetes. For frail older adults, adaptive formats — chair-based exercise, water aerobics, tai chi, walking programs — provide equivalent metabolic benefits with reduced injury risk. Resistance training 2–3 times per week to preserve muscle mass is particularly important. Exercise should be adapted to individual functional capacity and comorbidities, and both falls prevention and glucose monitoring before and after exercise should be part of the exercise planning conversation with the diabetes care team. Our guide on diabetes and foot health covers the footwear and foot inspection practices that make safe exercise possible for older adults with neuropathy and foot vulnerabilities.

Comprehensive Goals of Care in Older Adults With Diabetes

The shift in diabetes management goals for older adults reflects a fundamental recognition: in younger adults, the primary goal of glucose control is to prevent complications that manifest over 10–20 year timelines — retinopathy, nephropathy, neuropathy, and cardiovascular disease. These long-term endpoints remain relevant for healthy older adults with reasonably long life expectancy. But as age advances and comorbidity burden increases, the risk-benefit calculation shifts. Tight glucose control with its hypoglycemia risks may cause more harm in the near term than it prevents in the long term for the oldest and frailest patients.

The ADA classifies older adults with diabetes into three health categories for the purpose of individualizing targets:

Healthy (few comorbidities, intact cognition): HbA1c below 7.5%, blood pressure below 140/90 mmHg, LDL below 100 mg/dL. Full preventive care including statin therapy, ACE inhibitors where indicated, retinal screening, and foot exams. This group benefits from the same evidence-based preventive targets as younger adults, and intensive management is appropriate and beneficial.
Complex (multiple chronic conditions, mild-moderate cognitive impairment, early functional limitations): HbA1c below 8.0%, less stringent blood pressure targets (below 150/90 mmHg acceptable), individualized lipid management. Simplify regimens to reduce pill burden, prioritize hypoglycemia avoidance, maintain function. Our guide on diabetes and high blood pressure covers how blood pressure targets are adjusted in this complex older adult group.
Very complex/poor health (end-stage organ failure, significant cognitive impairment, high functional dependence, limited life expectancy): HbA1c below 8.5%, focus entirely on avoiding symptomatic hyperglycemia (thirst, frequent urination, infections) and hypoglycemia rather than preventing long-term complications. Deprescribe where possible to reduce treatment burden. Comfort and quality of life are the primary goals in this category, and glucose control serves symptom management rather than complication prevention.

This stratification represents a mature, evidence-based approach to prioritizing patient-centered outcomes over algorithmic glucose targets. It does not mean giving up on older adults with diabetes — it means tailoring care to what actually benefits them at their current health stage, which is ultimately more respectful of their goals and values than rigid universal targets. Our guide on what is insulin resistance covers the metabolic changes that make glucose management increasingly complex in older adults as insulin resistance often worsens with age-related sarcopenia.

Diabetes Technology in Older Adults

Continuous glucose monitoring (CGM) technology has expanded dramatically in utility for older adults with diabetes, despite the common assumption that older adults cannot or will not use technology. Several points deserve emphasis:

CGM reduces hypoglycemia in older adults: The real-time alerts of CGM — when glucose is falling or has fallen below a set threshold — provide a safety net for older adults with impaired hypoglycemia awareness who may not experience classical warning symptoms. Studies in older adults with Type 1 and Type 2 diabetes on insulin demonstrate significant reductions in time-below-range and severe hypoglycemia events with CGM use compared to fingerstick monitoring alone. This benefit is particularly valuable for the population at highest risk of hypoglycemic falls and cardiac events.
Simplified CGM devices for older adults: The CGM landscape now includes devices designed for ease of use that display glucose directly on a separate reader (without requiring a smartphone), have large readable displays, require infrequent sensor changes, and are worn on the arm rather than the abdomen — reducing the complexity of use for older adults with limited manual dexterity or smartphone proficiency. Libre 3 and Dexcom G7 both have features that facilitate older adult use, and the Abbott Libre View system is often cited for its simplicity.
Caregiver integration: CGM systems that share data with family caregivers or care facility staff via phone or online platforms provide an additional safety layer for older adults with dementia or functional limitations who cannot independently respond to low glucose alerts. This caregiver integration transforms CGM from an individual management tool to a family-supported safety system — an important consideration when evaluating CGM for older adults living with care support.
Closed-loop insulin delivery: Hybrid closed-loop systems (automated insulin delivery systems) that combine CGM with an insulin pump to automatically adjust basal insulin delivery are increasingly used in older adults with Type 1 diabetes, with compelling evidence for hypoglycemia reduction and improved time-in-range compared to multiple daily injection regimens. While still predominantly used in Type 1 diabetes, their role in insulin-dependent Type 2 diabetes in older adults is expanding.

Healthcare teams should not assume that an older patient’s age precludes technology adoption without actually assessing their interest and capacity. Many older adults are highly motivated to adopt devices that reduce the burden of fingerstick testing or improve their safety from hypoglycemia, and with appropriate training and support, a large proportion can use CGM effectively. Our guide on diabetes and eye health covers retinopathy-related visual impairment considerations that may affect an older adult’s ability to read CGM displays and select appropriately sized or voice-enabled devices.

Social and Environmental Factors in Diabetes and Healthy Aging

Diabetes outcomes in older adults are profoundly shaped by social determinants and environmental factors that the traditional clinical focus on glucose, blood pressure, and lipids does not adequately capture:

Social isolation and loneliness: Social isolation is an independent risk factor for poor diabetes outcomes, depression, cognitive decline, and mortality in older adults. Isolated older adults with diabetes are less likely to adhere to medications, less likely to monitor blood glucose, less likely to maintain healthy diet and exercise behaviors, and more likely to experience undetected hypoglycemic episodes. Healthcare teams should screen for social isolation (the UCLA Loneliness Scale or simple direct questioning) and connect isolated patients with community programs — diabetes support groups, senior centers, congregate meal programs, and volunteer visitor programs — that provide both social connection and diabetes management support.
Food security: Food insecurity — the inability to reliably access adequate, nutritious food — is more prevalent among older adults than often recognized, affecting approximately 8–10% of Americans over 65, with higher rates among racial and ethnic minorities and those with lower incomes. Older adults with diabetes who are food insecure are at higher risk for both hypoglycemia (skipping meals due to food unavailability) and hyperglycemia (relying on cheap, calorie-dense, nutrient-poor foods when food is available). Screening for food insecurity and connecting patients to SNAP (Supplemental Nutrition Assistance Program), Meals on Wheels, food pantries, and subsidized produce programs are legitimate and important clinical interventions. Our guide on diabetes and oral health covers the dental barriers — particularly tooth loss — that limit food choices and compound nutritional challenges in older adults with diabetes.
Transportation barriers: Transportation access affects the ability of older adults with diabetes to attend medical appointments, fill prescriptions, and access healthy food — fundamental logistics that determine whether optimal care can be received and maintained. Telehealth visits have significantly improved access to diabetes care for older adults with transportation limitations, and telemedicine for diabetes management (including CGM data review, medication adjustments, and diabetes education) has shown effectiveness comparable to in-person care for appropriate patients. Advocating for telehealth access and transportation assistance programs is part of comprehensive diabetes care for older adults.
Housing and safety: Safe, accessible housing is a foundation for diabetes self-management in older adults. Fall hazards in the home environment — loose rugs, poor lighting, inadequate bathroom grab bars, cluttered pathways — are important contributors to diabetes-related fall risk that can be addressed through home safety assessments and modification programs. For older adults with significant mobility limitations, home health visits from diabetes nurses and dietitians can provide diabetes management support in the home environment that would otherwise be inaccessible.

Planning for the Long Term With Diabetes

Diabetes and healthy aging extends beyond medical management to encompass advance care planning — the process of thinking through, discussing, and documenting preferences for future healthcare in the event of incapacity or serious illness. Several diabetes-specific dimensions are worth highlighting:

Designating a healthcare proxy: Older adults with diabetes should designate a trusted person as healthcare proxy (healthcare power of attorney) who can make medical decisions if they are unable to do so — from hypoglycemia-related incapacity to more serious medical events. This proxy should understand the person’s diabetes management, including medication regimens, hypoglycemia recognition and treatment, and the person’s values around aggressive versus comfort-focused care.
Medication preferences near end of life: For people approaching end of life with advanced diabetes, continuing tight glucose control with its medication burden, injection requirements, and monitoring demands may no longer align with quality-of-life goals. A proactive conversation about when and how to de-intensify diabetes treatment — reducing medication burden, relaxing glucose targets, stopping routine monitoring — is an important component of advance care planning that relieves unnecessary burden in life’s final chapter.
Staying informed about evolving treatments: Diabetes management is an active research field with new medications, devices, and approaches emerging regularly. Older adults with diabetes who remain engaged with their care team, participate in diabetes education, and stay informed through reputable sources — the American Diabetes Association’s patient resources at diabetes.org/older-adults, the NIDDK’s diabetes in older adults resource, and the AGS HealthInAging Foundation — are best positioned to benefit from improvements in care. Our guide on prediabetes symptoms and prevention covers the upstream prevention opportunities relevant for older adults and their family members who may be at elevated risk.

Sources: American Diabetes Association. “Older Adults: Standards of Medical Care in Diabetes.” Diabetes Care 2024. | NIDDK — Diabetes in Older Adults. | Mayo Clinic — Diabetes Treatment in Older Adults. | American Geriatrics Society — Beers Criteria 2023. | Kirkman MS, et al. “Diabetes in Older Adults.” Diabetes Care 2012.